PH12019502874A1 - Antibacterial activity of galactooligosaccharide and xylitol in dermatological treatments - Google Patents

Antibacterial activity of galactooligosaccharide and xylitol in dermatological treatments

Info

Publication number
PH12019502874A1
PH12019502874A1 PH12019502874A PH12019502874A PH12019502874A1 PH 12019502874 A1 PH12019502874 A1 PH 12019502874A1 PH 12019502874 A PH12019502874 A PH 12019502874A PH 12019502874 A PH12019502874 A PH 12019502874A PH 12019502874 A1 PH12019502874 A1 PH 12019502874A1
Authority
PH
Philippines
Prior art keywords
galactooligosaccharide
xylitol
antibacterial activity
dermatological treatments
dermatological
Prior art date
Application number
PH12019502874A
Other languages
English (en)
Inventor
Andrea Zanardi
Alessandra Ceraci
Ivan Montaldo
Original Assignee
Rottapharm Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rottapharm Spa filed Critical Rottapharm Spa
Publication of PH12019502874A1 publication Critical patent/PH12019502874A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A61K8/062—Oil-in-water emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/604—Alkylpolyglycosides; Derivatives thereof, e.g. esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59—Mixtures
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59—Mixtures
    • A61K2800/592—Mixtures of compounds complementing their respective functions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
PH12019502874A 2017-06-27 2019-12-19 Antibacterial activity of galactooligosaccharide and xylitol in dermatological treatments PH12019502874A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762525489P 2017-06-27 2017-06-27
PCT/EP2018/067337 WO2019002421A1 (en) 2017-06-27 2018-06-27 ANTIBACTERIAL ACTIVITY OF GALACTO-OLIGOSACCHARIDE AND XYLITOL IN DERMATOLOGICAL TREATMENTS

Publications (1)

Publication Number Publication Date
PH12019502874A1 true PH12019502874A1 (en) 2020-10-05

Family

ID=62816525

Family Applications (1)

Application Number Title Priority Date Filing Date
PH12019502874A PH12019502874A1 (en) 2017-06-27 2019-12-19 Antibacterial activity of galactooligosaccharide and xylitol in dermatological treatments

Country Status (12)

Country Link
US (1) US11234997B2 (https=)
EP (2) EP4241855A3 (https=)
JP (1) JP7170002B2 (https=)
KR (1) KR102675209B1 (https=)
AU (1) AU2018293307B2 (https=)
BR (1) BR112019027089B1 (https=)
ES (1) ES2948510T3 (https=)
MY (1) MY203497A (https=)
NZ (1) NZ759173A (https=)
PH (1) PH12019502874A1 (https=)
SA (1) SA519410993B1 (https=)
WO (1) WO2019002421A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201900031D0 (en) * 2019-01-02 2019-02-13 Rottapharm Spa Antibacterial oral compositions
GB201911071D0 (en) * 2019-08-02 2019-09-18 Meda Pharma S P A Antibacterial activity of selected prebiotic oligosaccharides and xylitol in dermatological treatment
JP2023516922A (ja) * 2020-02-25 2023-04-21 ユニリーバー・アイピー・ホールディングス・ベスローテン・ヴェンノーツハップ プレバイオティックな有益性のための糖類とグリセロールの組み合わせの使用
DE102020133860A1 (de) 2020-12-16 2022-06-23 MNT Systeme GmbH VERWENDUNG VON β-GALAKTOOLIGOSACCHRIDEN FÜR DIE HERSTELLUNG EINER KOSMETISCHEN UND/ODER PHARMAKOLOGISCH WIRKSAMEN ZUSAMMENSETZUNG
JP2022102000A (ja) * 2020-12-25 2022-07-07 物産フードサイエンス株式会社 吸血昆虫の誘引抑制剤および吸血昆虫誘引菌の菌数抑制剤
JPWO2022230925A1 (https=) * 2021-04-28 2022-11-03

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2678166B1 (fr) * 1991-06-27 1993-10-22 Bioeurope Compositions cosmetiques contenant des glucooligosaccharides.
JP2000302673A (ja) * 1999-04-22 2000-10-31 Shiseido Co Ltd アトピー性皮膚炎用皮膚外用剤
JP4011787B2 (ja) * 1999-04-22 2007-11-21 株式会社資生堂 選択的抗菌組成物
JP2002302404A (ja) * 2001-04-02 2002-10-18 Shiseido Co Ltd 抗菌防黴助剤
JP2008156308A (ja) * 2006-12-26 2008-07-10 Lion Corp 口腔用組成物
JP5207664B2 (ja) 2007-06-04 2013-06-12 株式会社シャネル化粧品技術開発研究所 化粧品
CN104105470A (zh) 2012-02-14 2014-10-15 宝洁公司 皮肤共生益生元剂和包含其的组合物的局部使用
CN103462881B (zh) * 2013-10-10 2016-06-22 深圳市容大生物技术有限公司 一种可促进皮肤微生态平衡的组合物及其制备方法
JP2016196435A (ja) * 2015-04-06 2016-11-24 コーベビオケミア株式会社 スキンケア用組成物
CN104970176A (zh) * 2015-07-02 2015-10-14 广州普正生物科技有限公司 复合真菌多糖凝胶糖果
CN105796377A (zh) 2016-03-18 2016-07-27 西安膳方医药科技有限公司 一种通过微生态调整改善生物体表健康的方法
AU2017240656A1 (en) * 2016-03-31 2018-11-15 Gojo Industries, Inc. Topical composition for reducing pathogen binding
CN106071033A (zh) 2016-05-12 2016-11-09 南京泽朗生物科技有限公司 一种含益生元的冰激凌及其制备方法
CN106616602A (zh) 2016-12-09 2017-05-10 宁夏沃福百瑞枸杞产业股份有限公司 一种黑枸杞益生菌片的制备方法

Also Published As

Publication number Publication date
ES2948510T3 (es) 2023-09-13
NZ759173A (en) 2022-11-25
WO2019002421A1 (en) 2019-01-03
RU2020102673A3 (https=) 2021-09-10
MY203497A (en) 2024-06-30
KR20200024786A (ko) 2020-03-09
KR102675209B1 (ko) 2024-06-17
EP4241855A2 (en) 2023-09-13
AU2018293307A1 (en) 2019-12-05
US20200171070A1 (en) 2020-06-04
JP7170002B2 (ja) 2022-11-11
EP4241855A3 (en) 2023-10-25
EP3644945C0 (en) 2023-06-07
SA519410993B1 (ar) 2023-10-16
JP2020525460A (ja) 2020-08-27
BR112019027089B1 (pt) 2023-04-25
AU2018293307B2 (en) 2023-09-21
US11234997B2 (en) 2022-02-01
EP3644945A1 (en) 2020-05-06
EP3644945B1 (en) 2023-06-07
BR112019027089A2 (pt) 2020-07-07
RU2020102673A (ru) 2021-07-27

Similar Documents

Publication Publication Date Title
PH12019502874A1 (en) Antibacterial activity of galactooligosaccharide and xylitol in dermatological treatments
SA521421897B1 (ar) تركيبة تعتمد على جزء من نباتات طبية أو مستخلصاتها واستخداماتها ومنتجاتها
EP4442241A3 (en) Retinol replacement in skin treatment
MX2016009666A (es) Suministro topico de composiciones para la piel que tienen ph bajo.
MX2021010058A (es) Formulaciones de rapamicina tópicas y su uso en el tratamiento de angiofibromas faciales y otros trastornos de la piel.
WO2017136600A8 (en) Compositions and methods for invasive and non-invasive procedural skincare
MY199967A (en) Combinations of lsd1 inhibitors for use in the treatment of solid tumors
MX2011010859A (es) Peptidos utiles en el tratamiento y/o cuidado de la piel y/o cabello y su uso en composiciones cosmeticas o farmaceuticas.
CO6640250A2 (es) Formulación tópica que comprende (r)-3-ciclopentil-3-(4-(7h-pirrolo(2,3-d)pirimidin-4-il)-1h-pirazol-1-il)propanonitrilo o una sal farmaceúticamente aceptable del mismo y una emulsión de aceite en agua
PH12020500543A1 (en) Nonracemic mixtures and uses thereof
WO2017155232A3 (ko) 발모 촉진 활성 및/또는 멜라닌 생성 촉진 활성을 나타내는 펩타이드 및 이의 용도
HK1212251A1 (en) Topical compositions and methods of use
CA3010568A1 (en) Oromucosal nanofiber carriers for therapeutic treatment
WO2018106108A8 (en) Topical pharmaceutical composition containing phenytoin and a (co -)an algesic for the treatment of chronic pain
PH12020552142A1 (en) Composition for muscle relaxation
EP4552650A3 (en) Methods and compositions for treatment of skin
WO2017164609A3 (ko) 피부 재생 또는 상처 치료용 펩타이드 및 이의 용도
MX379253B (es) Formulaciones de oximetazolina estabilizadas y sus usos.
MX2021012353A (es) Composicion cosmetica topica y usos de la misma.
WO2013190542A3 (en) Topical compositions for the treatment of chronic inflammatory skin disease
MX382949B (es) Formulaciones tópicas de detomidina.
HK1221412A1 (zh) 囊泡
MX2020010747A (es) Formulaciones topicas que comprenden estroncio y metilsulfonilmetano (msm) y metodos de tratamiento.
SG11201909144VA (en) Bacterial secretome for use in the treatment of skin lesions
MX2021008812A (es) Composicion cosmetica/dermatologica.